Myrexis, Inc. (MYRX) Return on Investment ROI from the fourth quarter of 2013 to fourth quarter of 2012 and for the year 2013, average high and low, overall ranking from Jun 30 2013 to Jun 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Myrexis, Inc.  (MYRX)


Myrexis,'s ROI from its fourth quarter of 2013 to the fourth quarter of 2012 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Myrexis,'s ROI in the fourth quarter of 2013?
Myrexis, Inc. recorded a cumulative net loss of $-12 million during 12 months ending in the fourth quarter of 2013, resulting in a negative return on investment (ROI) of -27.21%.

Within the Healthcare sector 70 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2013 from 0 to 1212.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2013)
IV. Quarter		 (Mar 31 2013)
III. Quarter		 (Dec 31 2012)
II. Quarter		 (Sep 30 2012)
I. Quarter		 (Jun 30 2012)
IV. Quarter
Y / Y Investment Change TTM -56.85 % -38.97 % 6.07 % 63.42 % 235.68 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1 1 82 86 89
Return On Investment (TTM) -27.21 % -17.71 % -21.55 % -23.24 % -27.06 %
MYRX's Overall Ranking # 1212 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -34.05 % -26.23 % -5.66 % -5.98 % -6.73 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -11 -19 -22 -27

MYRX Company Profile >> Back to MYRX Roi Comparisons >> See Annual MYRX Return On Investment



Return On Investment MYRX's Ranking
Within: No.
Industry # 12
Sector # 71
Overall # 1212

Return On Investment Statistics
High Average Low
-27.21 %
-27.21 %
-27.21 %
(Jun 30 2013)  







Financial Statements
Myrexis,'s IV. Quarter Investments $ 1 Millions MYRX's Balance sheet
Myrexis,'s IV. Quarter Income $ 0 Millions Quarterly MYRX's Income Statement
MYRX's Income by Division See MYRX's Income by Division


MYRX Annual Return On Investment (Jun 30 2013)
2013		 (Jun 30 2012)
2012


Total Investments in Millions 1 89 0 0 0
Y / Y Investment Growth -98.7 % - - - -
Net Income in Millions -12 -31 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -999.23 % -34.92 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MYRX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MYRX's Competitors
Subscribers only: Roi for Myrexis,'s Suppliers
Subscribers only: Return On Investment for MYRX's Customers

Other Ratios
MYRX's Roa MYRX's Inventory Turnover Ratio MYRX's Growth Rates MYRX's Dividend Statistics
MYRX's Profitability Ratios MYRX's Asset Turnover Ratio MYRX's Dividend Growth
MYRX's Roe MYRX's Valuation Ratios MYRX's Financial Strength Ratios MYRX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2013, within Healthcare Sector ROI

Date modified: 2026-07-10T08:33:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.